Based on the therapeutic potential of catalase for PD, three years later, Kojima et al. [144] developed a series of synthetic biology-inspired control devices, which they call EXOsomal Transfer Into Cell (EXOtic) devices, to deliver the catalase mRNA delivery without the need to concentrate exosomes. This evidence concerns the gene CAT and Parkinson disease.